• 021-20985259

R&D Pipeline of Novamab

Project Target Indicatioin Immunization Library Construction Functional identification Humanization Efficacy study Cell line Process Development GMP manufacturing TOX study IND
LQ001 CD47 Lymphoma,Non-Hodgkin;Ovarian Cancer
LQ002 PD-L1 Non-Small Cell Lung Cancer;Breast Cancer
LQ008 PD-1 Non-Small Cell Lung Cancer;Breast Cancer
LQ004 PD-L1/XX Head and Neck Squamous Cell Carcinoma
LQ005 PD-1/XX LarynxCancer;Head and Neck Squamous CellCarcinoma
LQ007 CD47/XX Lymphoma,Non-Hodgkin;Ovarian Cancer
Shanghai Novamab Biopharmaceuticals Co., Ltd. Technical support:朗企科技